ArticleInfectious diseases in obstetrics and gynecology2012
Epidemiologic features of Vulvovaginal Candidiasis among reproductive-age women in India.
Article in Infectious diseases in obstetrics and gynecology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 93 citations in OpenAlex.
- Vulvovaginal candidiasis among Yemeni women: prevalence of Candida species, biofilm formation rates, antifungal susceptibility patterns, and biofilm-associated genes ALS1 and HWP1.BMC microbiology · 2026Article
- Genotypes analysis and antifungal susceptibility ofPakistan journal of medical sciences · 2024Article
- Second trimester vaginalFrontiers in global women's health · 2024Article
- Characteristics of the Skin Microbiome in Selected Dermatological Conditions: A Narrative Review.Life (Basel, Switzerland) · 2022Review
- Prevalence, species distribution and antifungal susceptibility of Candida albicans causing vaginal discharge among symptomatic non-pregnant women of reproductive age at a tertiary care hospital, Vietnam.BMC infectious diseases · 2021Article
- Curcumin-Loaded Micelles Dispersed in Ureasil-Polyether Materials for a Novel Sustained-Release Formulation.Pharmaceutics · 2021Article
- Identifying Risk Factors for Lower Reproductive Tract Infections among Women Using Reusable Absorbents in Odisha, India.International journal of environmental research and public health · 2021Article
- Observational
- Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of VaginalBioMed research international · 2021Article
- Vaginal microbiota evaluation and prevalence of key pathogens in ecuadorian women: an epidemiologic analysis.Scientific reports · 2020Article
- Associations between the vaginal microbiome and Candida colonization in women of reproductive age.American journal of obstetrics and gynecology · 2020Article
- Prevalence ofAfrican health sciences · 2020Article
- Ultraviolet A/blue light-emitting diode therapy for vulvovaginal candidiasis: a case presentation.Lasers in medical science · 2019Article
- Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern.BMC women's health · 2018Article
- Is human Dectin-1 Y238X gene polymorphism related to susceptibility to recurrent vulvovaginal candidiasis?Current medical mycology · 2016Article
- Efficacy of the clinical agent VT-1161 against fluconazole-sensitive and -resistant Candida albicans in a murine model of vaginal candidiasis.Antimicrobial agents and chemotherapy · 2015Article
- Performance of BVBlue rapid test in detecting bacterial vaginosis among women in Mysore, India.Infectious diseases in obstetrics and gynecology · 2014Article
- Detection of FUR1 Gene in 5-Flucytosine Resistant Candida Isolates in Vaginal Candidiasis Patients.Journal of clinical and diagnostic research : JCDR · 2013Article
- Prevalence of Candida spp. in cervical-vaginal samples and the in vitro susceptibility of isolates.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]Article
- Vulvovaginal Candidiasis in Aminu Kano Teaching Hospital, North-West Nigeria: Hospital-Based Epidemiological Study.Annals of medical and health sciences researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 4 institutions in 3 countries.
Funding
Abstract
backgroundVulvovaginal candidiasis is characterized by curd-like vaginal discharge and itching, and is associated with considerable health and economic costs. MATERIALS AND
methodsWe examined the incidence, prevalence, and risk factors for vulvovaginal candidiasis among a cohort of 898 women in south India. Participants completed three study visits over six months, comprised of a structured interview and a pelvic examination.
resultsThe positive predictive values for diagnosis of vulvovaginal candidiasis using individual signs or symptoms were low (<19%). We did not find strong evidence for associations between sociodemographic characteristics and the prevalence of vulvovaginal candidiasis. Women clinically diagnosed with bacterial vaginosis had a higher prevalence of vulvovaginal candidiasis (Prevalence 12%, 95% CI 8.2, 15.8) compared to women assessed to be negative for bacterial vaginosis (Prevalence 6.5%, 95% 5.3, 7.6); however, differences in the prevalence of vulvovaginal candidiasis were not observed by the presence or absence of laboratory-confirmed bacterial vaginosis.
conclusionsFor correct diagnosis of vulvovaginal candidiasis, laboratory confirmation of infection with Candida is necessary as well as assessment of whether the discharge has been caused by bacterial vaginosis. Studies are needed of women infected with Candida yeast species to determine the risk factors for yeast's overgrowth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.